FDA inspection
Celgene Corp., d.b.a. Abraxis BioScience LLC: FDA inspection ending Feb 26, 2009
FDA inspection 565068 · Voluntary Action Indicated (VAI) · Melrose Park, IL
Key facts
| Inspection ID | 565068 |
|---|---|
| Firm | Celgene Corp., d.b.a. Abraxis BioScience LLC |
| FEI number | 3006814961 |
| Address | 2020 N Ruby St |
| City | Melrose Park |
| State | IL |
| ZIP | 60160 |
| Country | United States |
| Fiscal year | 2009 |
| Inspection end date | Feb 26, 2009 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data